openPR Logo
Press release

Endometrial Cancer Treatment Market Insights and Analysis for Period ( 2017-2027)

09-19-2017 12:57 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Endometrial Cancer Treatment Market Insights and Analysis

Endometrial cancer or uterine cancer is one of the most common gynecological cancers and 2.8% of women are diagnosed with the endometrial cancer at some point in their lives. According to National Cancer Institute statistics, in 2015 endometrial cancer contributed to 1.8% of all cancers and 3.6% of all new cancer cases were diagnosed as endometrial cancer. Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial cancers are typically diagnosed as type I and type II tumors and majority of the patients diagnosed with endometrial cancer represent early-stage cancers. According to Yale University School of Medicine, U.S., in 2014, type I tumors constitute 80% of all cases of endometrial cancers diagnosed in the U.S. Endometrial cancer can be treated by one or combination of chemotherapy, radiation therapy and hormone therapy. Most of the physicians recommend combination treatments as chemotherapy alone has traditionally been deem ineffective. Adjuvant radiation therapy is preferred in patients who have diagnosed with sage I or II endometrial cancer. Radiation therapy is also recommended in patients who have undergone the surgery, in order to avoid the relapse of endometrial cancer. Endometrial cancer is often detected in women above the age of 50 years and risk of endometrial cancer increases with the age. Also the risk of development of endometrial cancer is more in breast cancer patients who are being treated with tamoxifen or estrogen for long time. Plenty of chemotherapeutic agents are available and are recommended in the combination for the treatment of endometrial cancer. Some of the combination therapies include carboplatin & paclitaxel, Cisplatin & doxorubicin, Carboplatin & docetaxel and others.

Endometrial Cancer Treatment Market: Drivers and Restraints

Increasing incidence of uterine serous carcinoma – a highly aggressive variant of endometrial cancer – and relapse of endometrial cancers in patients treated with chemotherapy are the prime factors driving the growth of global endometrial cancer treatment market over the forecast period. In 2014, uterine serous carcinoma represented 10% of all caseload of endometrial cancers in the U.S. Some of the risk factors of endometrial cancer include obesity, presence of polycystic ovarian syndrome, long-term consumption of birth control pills, delayed pregnancy etc. Increasing incidence of obesity in the women aged above 50 can lead to the growth of endometrial cancer treatment market. However, divergent nature of cancer and increasing stringency in the regulatory requirements are the prime factors limiting the growth of global endometrial cancer treatment market. Besides this, side effects related to chemotherapy, radiation therapy and hormone therapy also restricts the adoption of these agents for endometrial cancer treatment.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2834

Endometrial Cancer Treatment Market: Segmentation

The global endometrial cancer treatment market has been segmented on the basis of treatment type, end user, and geography.

Based on treatment type, the global endometrial cancer treatment market is divided into following:

Chemotherapy

Carboplatin

Paclitaxel

Ixabepilone

Others

Hormonal Therapy

Megestrol (Megace)

Medroxyprogesterone (PROVERA)

Others (anastrozole, letrozole, etc.)

Radiation Therapy

Whole Pelvic External-beam Radiation Therapy

Vaginal Brachytherapy

Surgery

Hysterectomy

Bilateral Salpingo-oophorectomy (removal of both fallopian tubes and ovaries)

Based on end user, the global endometrial cancer treatment market is segmented as below:

Retail Pharmacy

Hospital pharmacy

Clinics

Endometrial Cancer Treatment Market: Overview

Global market for endometrial cancer treatment is forecast to grow at moderate rate owing to less number of drugs approved for treatment of endometrial cancer. Despite of this, chemotherapy segment is expected to hold the highest share in the global endometrial cancer treatment market due to high adoption rate of chemotherapy over radiation and surgical treatment. Also chemotherapeutic agents such as carboplatin and paclitaxel are recommended as a first line of therapy in majority of the cases, which increases demand for these products. Recent FDA approval of IXEMPRA (ixabepilone) for use in the treatment of endometrial cancer treatment is expected to fuel the growth of global market over the forecast period.

Endometrial Cancer Treatment Market: Regional Wise Outlook

Geographically, the global endometrial cancer treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America will continue to hold largest share in the global endometrial cancer treatment market due to high incidence of uterine serous carcinoma. Europe is expected to hold the second largest share in the global market partly due to increasing product availability in the region. North America is expected to expand at the highest rate over the forecast period.

Visit For TOC@ https://www.futuremarketinsights.com/toc/rep-gb-2834

Endometrial Cancer Treatment Market: Key Players

Some of the players operating in the global endometrial cancer treatment market include R-Pharm-US LLC., Bristol-Myers Squibb Company, Pfizer Inc., AstraZeneca Plc., Novartis AG and others. The global endometrial cancer treatment market is expected to grow in future due to increasing investment by multinational companies in cancer research.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometrial Cancer Treatment Market Insights and Analysis for Period ( 2017-2027) here

News-ID: 726167 • Views: 117

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Endometrial

Global Endometrial Ablation Market : Key Industry Developments
The presence of a number of large endometrial ablation enterprises such as Cooper Surgical Inc., Medtronic Plc, Boston Scientific Corp., Ethicon Inc., and Hologic Corp., has rendered the vendor landscape of the global endometrial ablation market highly competitive, observes Transparency Market Research in a recent report. To supersede competitors, companies in the market are focusing on growth strategies such as introduction of technologically advanced products and expansion across new regional
Endometrial Ablation Market - Global Industry Insights, 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Endometrial Ablation Market - Global Industry Insights 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Endometrial Biopsy Catheter Market Technological Breakthroughs
Perimenopausal and postmenopausal (absence of menstruation for 12 months or longer) women usually come across problems of abnormal uterine bleeding. Endometrial biopsy is a safe and efficient procedure for sampling the endometrium in a patient experiencing abnormal uterine bleeding to diagnose the condition and provide appropriate treatment. An endometrial suction catheter is used to carry out the biopsy. Endometrial biopsy catheters are easy to use, and have diagnostic accuracy which
Endometrial Ablation Market Growth Analysis 2024
TMR estimates that the global market for endometrial ablation will exhibit a promising CAGR of 5.50% from 2016 to 2024, rising from an opportunity worth US$0.8 bn in 2015 to US$1.3 bn by 2024. Rising Rate of Incidence of Gynecological Diseases to Drive Market The market is expected to benefit from a number of factors, which will be seen in its steady growth path over the course of the report’s forecast. The
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world. Download The